AU3846297A - Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system - Google Patents

Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system

Info

Publication number
AU3846297A
AU3846297A AU38462/97A AU3846297A AU3846297A AU 3846297 A AU3846297 A AU 3846297A AU 38462/97 A AU38462/97 A AU 38462/97A AU 3846297 A AU3846297 A AU 3846297A AU 3846297 A AU3846297 A AU 3846297A
Authority
AU
Australia
Prior art keywords
treating
cell
nervous system
autoimmune diseases
peripheral nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38462/97A
Inventor
Ralf Gold
Andreas Weishaupt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3846297A publication Critical patent/AU3846297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU38462/97A 1996-07-18 1997-07-18 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system Abandoned AU3846297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19629095 1996-07-18
DE1996129095 DE19629095A1 (en) 1996-07-18 1996-07-18 Use of recombinant myelin protein for the treatment of T cell-mediated autoimmune diseases of the peripheral nervous system
PCT/DE1997/001535 WO1998003647A2 (en) 1996-07-18 1997-07-18 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system

Publications (1)

Publication Number Publication Date
AU3846297A true AU3846297A (en) 1998-02-10

Family

ID=7800236

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38462/97A Abandoned AU3846297A (en) 1996-07-18 1997-07-18 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system

Country Status (4)

Country Link
EP (1) EP0917573A2 (en)
AU (1) AU3846297A (en)
DE (1) DE19629095A1 (en)
WO (1) WO1998003647A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001511A1 (en) * 1987-08-11 1989-02-23 Medical University Of South Carolina Suppressive t lymphocyte cell lines and supernatant derivative thereof
EP0527199B2 (en) * 1990-05-01 2000-08-30 The Board Of Trustees Of The Leland Stanford Junior University Compositions for use in a method for treating a human suffering from multiple sclerosis
WO1995007096A1 (en) * 1993-09-06 1995-03-16 La Trobe University Treatment of autoimmune disease

Also Published As

Publication number Publication date
EP0917573A2 (en) 1999-05-26
DE19629095A1 (en) 1998-02-12
WO1998003647A2 (en) 1998-01-29
WO1998003647A3 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
AU9262598A (en) Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
AU4787697A (en) Therapeutic gene
AU4582797A (en) Methods for treatment of retinal diseases
AU4230196A (en) Treatment of pancreatic tumors with peptide yy and analogs thereof
AU5981098A (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
EP0723460A4 (en) Gene therapy of the nervous system
PL329851A1 (en) Treatment of diseases associated with vegf
AU6311696A (en) Recombinant protein having bacteriophage endosialidase enzymatic activity
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU3794997A (en) Treatment for itch of chicken pox
AU6282896A (en) Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
AU1059095A (en) Treatment of viral disease with cd40l peptide
AU5389096A (en) Human hematopoietic-specific protein
AU4518396A (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
EP1039883A4 (en) Methods for the treatment of apolipoprotein e related diseases
GB9419021D0 (en) Therapeutic protein
AU1769497A (en) Modified cytokines for therapeutic use
AU5020196A (en) Human fas gene promoter region
AU4963696A (en) Head rest assembly for spas and whirlpools
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
AU5125298A (en) Bicistronic recombinant viruses useful for the treatment of dyslipoproteinemia-related pathologies
AU6517398A (en) Therapeutic agent for autoimmune diseases
AU3846297A (en) Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system
AU4582597A (en) Therapeutic proteins